AAMU
ATRS

Amundi Asset Management US’s Antares Pharma, Inc. ATRS Stock Holding History

Amundi Asset Management US’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$4.64M Buy
+1,129,569
New +$4.89M ﹤0.01% 1029
2019
Q2 		– Sell
-240,962
Closed -$730K – 1717
2019
Q1 		$730K Buy
+240,962
New +$781K ﹤0.01% 1266

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Amundi Asset Management US's ATRS Position: Q1 2021 in Review

Amundi Asset Management US opened a new position in Antares Pharma, Inc. (ATRS) in Q1 2021: 1,129,569 shares worth $4.64M. The stake represents ﹤0.01% of the portfolio and ranks #1029 among its holdings. This is a return to the name: Amundi Asset Management US previously reported a position in ATRS as recently as Q1 2019.

Amundi Asset Management US first reported a position in ATRS in Q1 2019 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • Amundi Asset Management US held 1,129,569 shares of Antares Pharma, Inc. worth $4.64M as of Q1 2021.
  • Antares Pharma, Inc. was a new Amundi Asset Management US position in Q1 2021.
  • Antares Pharma, Inc. made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1029 holding.
  • Amundi Asset Management US first reported a position in Antares Pharma, Inc. in Q1 2019 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.